全球HLA型检测市场规模、份额、趋势和成长分析报告（2026-2034年）

HLA型检测市场预计将从 2025 年的 13.9 亿美元成长到 2034 年的 25.7 亿美元，2026 年至 2034 年的复合年增长率为 7.04%。

由于器官移植手术数量的增加以及人们对组织相容性检测意识的提高，全球HLA型检测市场正经历显着成长。人类白血球抗原（HLA）分型在骨髓和固态器官移植中发挥着至关重要的作用。慢性疾病导致的器官衰竭病例不断增加，推动了全球对精准、先进的HLA检测解决方案的需求。

关键成长要素包括分子诊断技术的进步，例如次世代定序(NGS) 和基于 PCR 的检测。捐赠者登记系统的扩展和政府对移植项目的支持也促进了市场成长。免疫学和个人化医疗领域的研究进一步增强了临床和研究环境中对精准HLA型检测的需求。

预计未来成长将主要由技术创新、检查室自动化以及全球器官移植数量的增加所驱动。新兴市场对医疗基础设施的投资正在不断推进，从而创造了新的机会。此外，生物资讯工具的整合将提高数据分析的准确性，进而提升检测的精确度和效率，从而支持市场的持续扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球HLA型检测市场：依产品划分

• 市场分析、洞察与预测
• 装置
• 试剂和耗材
• 软体和服务

第五章：全球HLA型检测市场：依应用领域划分

• 市场分析、洞察与预测
• 诊断
• 研究

第六章：全球HLA型检测市场：依方法论划分

• 市场分析、洞察与预测
• 分子检测
• 基于序列的分子检测
• 非分子检测

第七章 全球HLA型检测市场：依最终用户划分

• 市场分析、洞察与预测
• 商业服务供应商
• 医院及移植中心
• 研究机构和学术机构

第八章：全球HLA型检测市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories Inc
  • Qiagen NV
  • Omixon Inc
  • GenDx
  • Illumina Inc
  • TBG Diagnostics Limited
  • Dickinson And Company
  • Takara Bio Inc
  • F. Hoffman-La Roche Limited
  • Pacific Biosciences

The HLA Typing Market size is expected to reach USD 2.57 Billion in 2034 from USD 1.39 Billion (2025) growing at a CAGR of 7.04% during 2026-2034.

The Global HLA Typing Market is witnessing strong growth due to increasing organ transplantation procedures and rising awareness about tissue compatibility testing. Human Leukocyte Antigen (HLA) typing plays a critical role in bone marrow and solid organ transplants. Growing cases of chronic diseases leading to organ failure are boosting demand for accurate and advanced HLA testing solutions worldwide.

Key growth drivers include advancements in molecular diagnostic technologies such as next-generation sequencing (NGS) and PCR-based assays. Expanding donor registries and government support for transplant programs are also contributing to market growth. Research in immunology and personalized medicine further strengthens the demand for precise HLA typing in clinical and research settings.

Future growth is expected to be driven by technological innovations, automation in laboratories, and increasing global transplant volumes. Emerging markets are investing in healthcare infrastructure, which will create new opportunities. Additionally, the integration of bioinformatics tools for improved data analysis will enhance testing accuracy and efficiency, supporting sustained market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instruments
• Reagents & Consumables
• Software & Services

By Application

• Diagnosis
• Research

By Technique

• Molecular Assay
• Sequenced-based Molecular Assay
• Non-Molecular Assay

By End User

• Commercial Service Providers
• Hospitals and Transplant Centers
• Research Labs & Academic Institutes

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, BioRad Laboratories Inc, Qiagen NV, Omixon Inc, GenDx, Illumina Inc, TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc, F HoffmanLa Roche Limited, Pacific Biosciences
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HLA TYPING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HLA TYPING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HLA TYPING MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technique
• 6.2. Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sequenced-based Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Non-Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HLA TYPING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Commercial Service Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals and Transplant Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research Labs & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HLA TYPING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Application
  • 8.2.3 By Technique
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Application
  • 8.3.3 By Technique
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Application
  • 8.4.3 By Technique
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Application
  • 8.5.3 By Technique
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Application
  • 8.6.3 By Technique
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HLA TYPING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Bio-Rad Laboratories Inc
  • 10.2.3 Qiagen N.V
  • 10.2.4 Omixon Inc
  • 10.2.5 GenDx
  • 10.2.6 Illumina Inc
  • 10.2.7 TBG Diagnostics Limited
  • 10.2.8 Dickinson And Company
  • 10.2.9 Takara Bio Inc
  • 10.2.10 F. Hoffman-La Roche Limited
  • 10.2.11 Pacific Biosciences